Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults: AHRQ Executive Summary CME

Disclosures

Release Date: March 13, 2008; Valid for credit through March 13, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

  1. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults: AHRQ Executive Summary
    Agency for Healthcare Research and Quality

  2. Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the epidemiology and treatment strategies for rheumatoid arthritis
  2. Compare disease-modifying antirheumatic drug regimens for patients with rheumatoid arthritis
Authors and Disclosures

Agency for Healthcare Research and Quality (AHRQ)
Disclosure: Content provided for Agency for Healthcare Research by the Duke Evidence-based Practice Center (EPC). None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report. (http://effectivehealthcare.ahrq.gov/
repFiles/ACEI_ARBFullReport.pdf)


Carol Peckham
Disclosure: Carol Peckham has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.